False-positive findings for tumor markers after curative gastrectomy for gastric cancer

Digestive Diseases and Sciences

Volumn 53, Issue 1, 2008, Pages 73-79

  Ohtsuka, Takao ^a   Sato, Seiji ^a   Kitajima, Yoshihiko ^a   Tanaka, Masayuki ^a   Nakafusa, Yuji ^a   Miyazaki, Kohji ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

False positive; Gastrectomy; Gastric cancer; Tumor marker

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

AGED; ARTICLE; BRONCHITIS; CANCER RECURRENCE; CANCER STAGING; DIABETES MELLITUS; DISEASE FREE INTERVAL; DISEASE MARKER; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; GASTRECTOMY; HUMAN; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 37249086687     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-9825-1     Document Type: Article

References (26)

1. Gold P, Freedman SO (1965) Demonstration of tumor-specific antigens in human colon carcinoma by immunological tolerance and absorption techniques. J Exp Med 121:439-462
2. Koprowski H, Herlyn M, Steplewski Z, Sears HF (1981) Specific antigen in serum of patients with colon carcinoma. Science 212:53-55
3. Tamada R, Hiramoto Y, Tsujitani S, Nozuka T, Okamura T, Masuda H, Sugimachi K, Inokuchi K (1985) Serum CEA level facilitate detection of recurrences of cancer in patients after gastrectomy. Jpn J Surg 15:23-29
4. Hamazoe R, Maeta M, Matsui T, Shibata S, Shiota S, Kaibara N (1992) CA72-4 compared with carcinoembryonic antigen as a tumor marker for gastric cancer. Eur J Cancer 28A:1351-1354
5. Sakamoto J, Nakazato H, Teramukai S, Ohashi Y, Takahashi Y, Mai M, Toge T, Okura H, Kodaira S, Maetani S, Okajima K, Nomoto K, Hattori T, Inokuchi K (1996) Association between preoperative plasma CEA levels and the prognosis of gastric cancer following curative resection. Tumor Marker Committee, Japanese Foundation for Multidisciplinary Treatment of Cancer, Tokyo, Japan. Surg Oncol 5:133-139
6. Ikeda Y, Mori M, Kajiyama K, Kamakura T, Maehara Y, Haraguchi Y, Sugimachi K (1996) Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of Stage II and III gastric cancer. Hepatogastroenterology 43:1281-1287
7. Tas F, Faruk Aykan N, Aydiner A, Yasasever V, Topuz E (2001) Measurement of serum CA19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer. Am J Clin Oncol 24:148-149
8. Ishigami S, Natsugoe S, Hokita S, Che X, Tokuda K, Nakajo A, Iwashige H, Tokushige M, Watanabe T, Takao S, Aikou T (2001) Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer. J Clin Gastroenterol 32:41-44
9. Lai IR, Lee WJ, Huang MT, Lin HH (2002) Comparison of serum CA72-4, CEA, TPA, CA19-9 and CA125 levels in gastric cancer patients and correlation with recurrence. Hepatogastroenterology 49:1157-1160
10. Takahashi Y, Takeuchi T, Sakamoto J, Touge T, Mai M, Ohkura H, Kodaira S, Okajima K, Nakazato H (2003) Tumor marker committee: the usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study. Gastric Cancer 6:142-145
11. Mihmanli M, Dilege E, Demir U, Coskun H, Eroglu T, Uysalol MD (2004) The use of tumor markers as predictors of prognosis in gastric cancer. Hepatogastroenterology 51:1544-1547
12. Nakamura N, Aoji O, Yoshikawa T, Mori K, Kajiyama S, Yoshihiro K, Kanatsuna T, Kondo M (1986) Elevated serum CA19-9 levels in poorly controlled diabetic patients. Jap J Med 25:278-280
13. Marechal F, Berthiot G, Deltour G. (1988) Serum levels of CA-50, CA19-9, CA-125, CA15-3, enolase and carcino-embryonic antigen in non neoplastic diseases of the lung. Anticancer Res 8:677-680
14. Osswald BR, Klee FE, Wysocki S (1993) The reliability of highly elevated CA19-9 levels. Dis Markers 11:275-278
15. Nomura F, Koyama A, Ishijima M, Takano S, Narita M, Nakai T (1998) Serum levels of five tumor markers for lung cancer in patients with chronic renal failure. Oncol Rep 5:389-392
16. Giannini E, Borro P, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romaqnoli P, Testa E, Risso D, Lantieri PB, Antonucci A, Boccato M, Milone S, Testa R (2000) Cholestasis is the main determinant of abnormal CA 19-9 levels in patients with liver cirrhosis. Int J Biol Markers 15:226-230
17. Klapdor R, Bahlo M, Babinski A (2003) Atypical courses of serum tumor markers-4 case reports. Anticancer Res 23:845-850
18. Nio Y, Tsubono M, Kawabata K, Masai Y, Hayashi H, Meyer C, Inoue K, Tobe T (1993) Comparison of survival curves of gastric cancer patients after surgery according to the UICC stage classification and the general rules for gastric cancer study by the Japanese research society for gastric cancer. Ann Surg 218:47-53
19. D'Angelica M, Gonen M, Brennan MF, Turnbull AD, Bains M, Karper MS (2004) Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 240:808-816
20. Siewert JR, Bottcher K, Stein HJ, Roder JD (1998) Relevant prognostic factors in gastric cancer: ten-year results of the German gastric cancer study. Ann Surg 228:449-461
21. Kooby DA, Suriawinata A, Klimstra DS, Brennan MF, Karpeh MS (2003) Biologic predictors of survival in node-negative gastric cancer. Ann Surg 237:828-835
22. Moreaux J, Bougaran J (1993) Early gastric cancer. A 25-year surgical experience. Ann Surg 217:347-355
23. Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F (2005) Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 241:247-255
24. Japanese gastric cancer association (1999) Japanese classification of gastric carcinoma, 13th edn. Tokyo, Kanehara
25. Tobe T, Kouchi M, Tanimura H, Huang CH (1967) Hyperglycemia after gastrectomy as a prediabetic state. Clinical study of 100 postgastrectomy patients. Arch Surg 94:836-840
26. Sudo T, Ishiyama K, Takemoto M, Kawamura M, Umemura H, Shiraha S, Kuyama T, Suzuki T, Tobe T (1982) Pancreatic endocrine function after total gastrectomy and truncal vagotomy. Am J Surg 144:539-544